Startseite The crystal structure of 3-((4-chloro-N-(2-methoxyethyl)benzamido)methyl)phenyl methanesulfonate, C18H20ClNO5S
Artikel Open Access

The crystal structure of 3-((4-chloro-N-(2-methoxyethyl)benzamido)methyl)phenyl methanesulfonate, C18H20ClNO5S

  • Yong Li , Yundeng Wu ORCID logo EMAIL logo und Jingjing Wang
Veröffentlicht/Copyright: 7. September 2022
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 237 Heft 6

Abstract

C18H20ClNO5S, monoclinic, P21/n (no. 14), a = 5.671(4) Å, b = 18.225(13) Å, c = 17.99(2) Å, β = 90.18(4)°, V = 1859(3) Å3, Z = 4, R gt (F) = 0.0316, wR ref (F 2) = 0.0813, T = 170 K.

CCDC no.: 2202400

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.07 × 0.05 × 0.03 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.35 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θ max, completeness: 27.7°, >99%
N(hkl)measured, N(hkl)unique, R int: 20,055, 4235, 0.034
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 3660
N(param)refined: 266
Programs: Bruker [1], Shelx [2, 3], Olex2 [4], Platon [5], [6], [7], [8], publCIF [9]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
Cl1 −0.35118 (7) 0.12364 (2) 0.25983 (2) 0.03702 (11)
S1 0.97888 (6) 0.32987 (2) 0.44830 (2) 0.02858 (10)
O1 0.36829 (19) 0.34174 (6) 0.06810 (5) 0.0332 (2)
O3 0.95976 (16) 0.38376 (6) 0.37859 (5) 0.0299 (2)
O4 1.19442 (19) 0.29120 (8) 0.43589 (7) 0.0510 (3)
O5 0.9487 (3) 0.37172 (7) 0.51376 (6) 0.0523 (3)
N1 0.36655 (19) 0.41534 (6) 0.16903 (6) 0.0224 (2)
C1 0.1824 (2) 0.26609 (8) 0.23332 (8) 0.0306 (3)
H1 0.318678 0.280532 0.260464 0.037*
C2 0.0367 (3) 0.21118 (8) 0.26164 (8) 0.0319 (3)
H2 0.075480 0.187726 0.307241 0.038*
C3 −0.1641 (2) 0.19108 (7) 0.22309 (8) 0.0265 (3)
C4 −0.2200 (3) 0.22358 (8) 0.15634 (8) 0.0302 (3)
H4 −0.358215 0.209648 0.129916 0.036*
C5 −0.0701 (3) 0.27734 (8) 0.12818 (8) 0.0287 (3)
H5 −0.106330 0.299300 0.081621 0.034*
C6 0.1313 (2) 0.29976 (7) 0.16635 (7) 0.0238 (3)
C7 0.2962 (2) 0.35439 (7) 0.13072 (7) 0.0239 (3)
C8 0.5344 (2) 0.46649 (8) 0.13390 (7) 0.0255 (3)
H8AAa 0.598621 0.443573 0.088351 0.031*
H8ABa 0.667708 0.475388 0.168433 0.031*
H8BCb 0.660571 0.437583 0.109737 0.031*
H8BDb 0.608970 0.496693 0.173237 0.031*
C11 0.2481 (2) 0.44299 (8) 0.23523 (7) 0.0243 (3)
H11A 0.131340 0.406251 0.252101 0.029*
H11B 0.161535 0.488434 0.222311 0.029*
C12 0.4169 (2) 0.45905 (7) 0.29784 (7) 0.0219 (3)
C13 0.6115 (2) 0.41351 (7) 0.31124 (7) 0.0224 (3)
H13 0.641527 0.372231 0.280426 0.027*
C14 0.7578 (2) 0.42985 (7) 0.36984 (7) 0.0245 (3)
C15 0.7211 (3) 0.49028 (8) 0.41532 (8) 0.0320 (3)
H15 0.827353 0.501108 0.454764 0.038*
C16 0.5257 (3) 0.53477 (8) 0.40207 (8) 0.0335 (3)
H16 0.496516 0.575858 0.433205 0.040*
C17 0.3747 (3) 0.51941 (7) 0.34402 (7) 0.0274 (3)
H17 0.241554 0.549882 0.335291 0.033*
C18 0.7423 (3) 0.26952 (9) 0.43723 (9) 0.0347 (3)
H18A 0.593786 0.296802 0.440734 0.052*
H18B 0.747924 0.232080 0.476299 0.052*
H18C 0.752231 0.245816 0.388432 0.052*
O2a 0.2271 (4) 0.52557 (12) 0.06773 (13) 0.0329 (7)
C9a 0.4224 (6) 0.53887 (18) 0.1139 (2) 0.0300 (8)
H9Aa 0.371518 0.564663 0.159522 0.036*
H9Ba 0.537841 0.570294 0.087701 0.036*
C10a 0.1265 (18) 0.5942 (5) 0.0447 (6) 0.0389 (16)
H10Aa −0.003707 0.585027 0.009971 0.058*
H10Ba 0.247446 0.623863 0.020087 0.058*
H10Ca 0.067186 0.620555 0.088282 0.058*
O2Ab 0.2539 (5) 0.56418 (14) 0.11011 (14) 0.0428 (9)
C9Ab 0.4238 (6) 0.51791 (18) 0.0758 (2) 0.0288 (8)
H9AAb 0.548334 0.548255 0.052594 0.035*
H9ABb 0.347165 0.488522 0.036191 0.035*
C10Ab 0.128 (2) 0.6092 (7) 0.0576 (7) 0.061 (3)
H10Db 0.239979 0.641397 0.031836 0.091*
H10Eb 0.011703 0.639047 0.083862 0.091*
H10Fb 0.048256 0.577794 0.021193 0.091*

  1. aOccupancy: 0.505 (4), bOccupancy: 0.495 (4).

Source of materials

In a representative experiment, approximately 0.2 g (0.5 mmol) 3-((4-chloro-N-(2-methoxyethyl)benzamido)methyl)phenyl methanesulfonate was dissolved in a few drops of DMSO in a vial. Several drops of Toluene were added into another vial. Both vials were sitting in a clear beaker sealed with tape for easy viewing and access. Over time the equilibrium of the vapor will exist between the two solvents. During this equilibration process colourless block crystals of the title compound were obtained within about a week.

Experimental details

A suitable crystal was selected and placed on a ‘Bruker APEX-II CCD’ diffractometer. Using Olex2 [4], the structure was solved with the ShelXT [2] structure solution program using Intrinsic Phasing and refined with the ShelXL [3] refinement package using Least Squares minimisation.

Secondary CH2, including C8(H8AA,H8AB), C8(H8BC,H8BD), C11(H11A,H11B), C9(H9A,H9B), C9A(H9AA,H9AB), were refined with riding coordinates. Aromatic/amide H, including C1(H1), C2(H2), C4(H4), C5(H5), C13(H13), C15(H15), C16(H16), C17(H17), were refined with riding coordinates. Methyls, including C18(H18A,H18B,H18C), C10(H10A,H10B,H10C), C10A(H10D,H10E,H10F), were refined as idealised rotating group. U iso values of hydrogen atoms were set to 1.2U eq of the parent atoms for all C(H) groups, C(H,H) groups, C(H,H,H,H) groups and at 1.5U eq for all C(H,H,H) groups.

Statistical disorder is noted in the terminal 2-methoxyethyl groups. For this disorder, distances and U iso /U aniso restraints and constraints were imposed on relative atoms. The C8, C9, O2, C10 and C8A, C9A, O2A, C10A are disordered almost equally over two sites with occupancies 0.505:0.495.

These papers [10], [11], [12] also give the results of this classic terminal 2-methoxyethyl disorder.

Comment

The N-substituted sulfonyloxybenzylamines are believed to have ability to improve the overall appearance of skin, including reversing skin wrinkles, by stimulating collagen production with cosmetic compositions comprising effective amounts [13], [14], [15].

To the best of our knowledge, this is the first article to report the structure containing the bioactive group of N-substituted sulfonyloxybenzylamine. The structure of another building block, 4-chlorobenzamide, has been reported by literature [16], [17], [18] as their main moiety.

The N-substituted sulfonyloxybenzylamines are also part of our continuing interest in synthesis, characterisation and understanding of hydrogen bonding schemes of related compounds [19, 20].

The asymmetric unit of the title structure contains one 3-((4-chloro-N-(2-methoxyethyl)benzamido)methyl)phenyl methanesulfonate molecule (cf. left part of the figure, only one component of each of the disordered 2-methoxyethyl groups is shown for clarity purpose). The bond lengths and angles within these moieties are in the expected ranges.

In the amide moiety, nitrogen (N1) and carbonyl groups (C7=O1) form p–π conjugation. As a result of conjugation, not only the bond length in the amide moiety tend to be equal, but also the four atoms connected to N1 and C7 are all on the same plane (R.M.S-Error = 0.000 Å for the contributing atoms O1, N1, C6, C7, C8). The conjugation of coplanar structures is also reported by literature [21], [22], [23]. This plane encloses an angle of 54.27° with the plane of the 4-chlorophenyl group (C1–C6), and 84.95° with another plane of the phenyl group (C12–C17). There are no classical hydrogen bonds found for the title compound, but five non classical hydrogen bonds. Two of them are intramolecular and the other three are intermolecular hydrogen bonds. In one component of the disordered 2-methoxyethyl groups, O1 participates in intramolecular hydrogen bonds (C8–H8AA⋯O1, D⋯A = 2.730(3) Å; cf. left part of the figure) to form a five-membered ring (C8–H8AA–O1–C7–N1). In another component of disordered 2-methoxyethyl groups, there is another intramolecular hydrogen bond (C11–H11B⋯O2A, D⋯A = 3.154(4) Å; this disordered 2-methoxyethyl group is not shown in the figure for clarity purpose). O3 of sulfonyloxybenzylamine is involved in nonclassic intermolecular hydrogen bond (C11–H11A⋯O3′; ′ = −1 + x, y, z, D⋯A = 3.243(4) Å). The right part of the figure (some hydrogen atoms are omitted for clarity) shows this hydrogen-bonded chains running along a axis.

O4 of sulfonyloxybenzylamine is involved in another non-classical intermolecular hydrogen bonds (C18–H18A⋯O4′, ′ = −1 + x, y, z, D⋯A = 3.132(3) Å) running along a axis (cf. right part of the figure).

The O1 of the amide group is not only involved in intramolecular hydrogen bond but also intermolecular hydrogen bonds (C18–H18B…O1′′′; ′′′ = 1/2 + x, 1/2 − y, 1/2 + z, D⋯A = 3.187(4) Å). This hydrogen-bonded chain running along c axis is shown in unit cell (cf. right part of the figure).

In total, the three intermolecular hydrogen bonding interactions construct a network parallel to the ac plane (cf. right part of the figure).

Corresponding author: Yundeng Wu, Technique Center, Jinling Pharmaceutical Company Limited, Nanjing, 210046, Jiangsu Province, People’s Republic of China, E-mail:

Acknowledgments

We gratefully acknowledge financial support by School of Chemical Engineering, Ningbo Polytechnic, and Ningbo Polytechnic Zhejiang Collaborative Innovation Center.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. Smart and Saint; Bruker AXS Inc.: Madison, WI, USA, 2014.Suche in Google Scholar

2. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Suche in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. Olex2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

5. Spek, A. L. Single-crystal structure validation with the program Platon. J. Appl. Crystallogr. 2003, 36, 7–13; https://doi.org/10.1107/s0021889802022112.Suche in Google Scholar

6. Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. 2009, D65, 148–155; https://doi.org/10.1107/s090744490804362x.Suche in Google Scholar

7. Spek, A. L. What makes a crystal structure report valid. Inorg. Chim. Acta. 2018, 470, 232–237; https://doi.org/10.1016/j.ica.2017.04.036.Suche in Google Scholar

8. Spek, A. L. CheckCIF validation ALERTS: what they mean and how to respond. Acta Crystallogr. 2020, E76, 1–11; https://doi.org/10.1107/s2056989019016244.Suche in Google Scholar

9. Westrip, S. P. publCIF: software for editing, validating and formatting crystallographic information files. J. Appl. Crystallogr. 2010, 43, 920–925; https://doi.org/10.1107/s0021889810022120.Suche in Google Scholar

10. Kooijman, H., Son, M., Tanase, S., Bouwman, E., Reedijk, J., Spek, A. L. μ-Oxo-bis{chloro[N-(2-methoxyethyl)-N,N-bis(pyridin- 2-ylmethyl)amine-κ4-N,N′,N′′,O]iron(III)} bis(trifluoromethanesulfonate)acetonitrile disolvate. Acta Crystallogr. 2005, E61, m1042–m1044; https://doi.org/10.1107/s1600536805013553.Suche in Google Scholar

11. El-Emam, A. A., Al-Abdullah, E. S., Asiri, H. H., Chantrapromma, S., Fun, H. K. 5-(Adamantan-1-yl)-3-[(2-methoxyethyl) sulfanyl]-4-phenyl-4H-1,2,4-triazole. Acta Crystallogr. 2012, E68, o2326.10.1107/S1600536812029510Suche in Google Scholar PubMed PubMed Central

12. Mohamad, R., Awang, N., Kamaludin, N. F., Jotani, M. M., Tiekink, E. R. T. [N-Benzyl-N-(2-phenylethyl) dithiocarbamato-κ2S,S′] triphenyltin (IV) and [bis(2-methoxyethyl)dithiocarbamato-κ2S,S′]triphenyltin (IV): crystal structures and Hirshfeld surface analysis. Acta Crystallogr. 2016, E72, 1480–1487; https://doi.org/10.1107/s2056989016014985.Suche in Google Scholar

13. Ptchelintsev, D. S., Lyga, J. W., Wyborski, R., Zheng, Q., Hwang, C. S. Cosmetic use of N-substituted sulfonyloxybenzylamines and related compounds. U.S. Patent 2014, 8, 815–265.Suche in Google Scholar

14. Lyga, J. W. Cosmetic use of substituted amino heterocyclic carbamoyl analogs and related compounds. U.S. Patent 2014, 8, 686–013.Suche in Google Scholar

15. Zheng, Q., Chen, S. W., Santhanam, U., Lyga, J. W. Compositions and methods for stimulation MAGP-1 to improve the appearance of skin. U.S. Patent 2015, 9, 132–294.Suche in Google Scholar

16. Aakeröy, C. B., Beatty, A. M., Helfrich, B. A., Nieuwenhuyzen, M. Do polymorphic compounds make good cocrystallizing agents? A structural case study that demonstrates the importance of synthon flexibility. Cryst. Growth Des. 2003, 3, 159–165.10.1021/cg025593zSuche in Google Scholar

17. Touillaux, R., Germain, G., Declercq, J. P., Van Meerssche, M., Wilante, C., Leroy, G. Structure de benzoates de fluoroalkyles. J. Fluor. Chem. 1982, 20, 3–8; https://doi.org/10.1016/s0022-1139(00)84011-7.Suche in Google Scholar

18. Otani, Y., Nagae, O., Naruse, Y., Inagaki, S., Ohno, M., Yamaguchi, K., Yamamoto, G., Uchiyama, M., Ohwada, T. An evaluation of amide group planarity in 7-azabicyclo [2.2.1] heptane amides. Low amide bond rotation barrier in solution. J. Am. Chem. Soc. 2003, 125, 15191–15199; https://doi.org/10.1021/ja036644z.Suche in Google Scholar PubMed

19. Li, Y., Wang, J. The crystal structure of 4-(methoxycarbonyl) benzoic acid, C9H8O4. Z. Kristallogr. N. Cryst. Struct. 2019, 234, 349–350; https://doi.org/10.1515/ncrs-2018-0408.Suche in Google Scholar

20. Li, Y., Wu, Y. D., Wang, J. The crystal structure of 4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol, C15H11ClFN3O2. Z. Kristallogr. N. Cryst. Struct. 2019, 234, 437–438; https://doi.org/10.1515/ncrs-2018-0445.Suche in Google Scholar

21. Calderon, S. N., Rothman, R. B., Porreca, F., Flippen–Anderson, J. L., McNutt, R. W., Xu, H., Smith, L. E., Bilsky, E. J., Davis, P., Rice, K. C. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(.alpha. R)-.alpha.-((2S, 5R)-4-Allyl-2, 5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide. Delta. Opioid receptor agonist. J. Med. Chem. 1994, 37, 2125–2128; https://doi.org/10.1021/jm00040a002.Suche in Google Scholar PubMed

22. Karlsen, H., Kolsaker, P., Rømmingb, C., Uggerudb, E. The analogy between C=O and C (CN)2. Part 2. 1 Structural properties of N,N-dialkylaminobenzamides and the analogously substituted 2-(phenylmethylene)propanedinitriles. J. Chem. Soc. Perkin Trans. 2 2002, 3, 404–409; https://doi.org/10.1039/b105532c.Suche in Google Scholar

23. King, J. A., Bryant, G. L. Structures of two N-acyl triethyl ammonium salts and one simple triethyl ammonium salt. Acta Crystallogr. 1991, C47, 2249–2252.10.1107/S0108270191005152Suche in Google Scholar
Received: 2022-07-24
Accepted: 2022-08-19
Published Online: 2022-09-07
Published in Print: 2022-12-16

© 2022 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of 1,5-bis(4-chlorophenyl)-3-(3-methylphenyl)pentane- 1,5-dione, C48H40Cl4O4
  4. Crystal structure of (bis(1,10-phenanthroline-κ 2 N,N′))-(3,5-dinitrosalicylato-κ 2 O,O′)nickel(II), C31H18N6NiO7
  5. Crystal structure of {N,N′-bis(4-fluoro-salicylaldehyde)-3,6-dioxa-1,8-diaminooctane-κ4 O,N,N′,O′}zinc(II), C20H20F2N2O4Zn
  6. [5-Bromo-2-(2-(dimethylamino)ethyliminomethyl)phenolato-κ3 N,N′,O]-isothiocyanato-nickel(II), C12H14BrN3NiOS
  7. Crystal structure of 9-bromo-4-(6-methoxypyridin-2-yl)-5,6-dihydrobenzo[h]quinazolin- 2-amine, C18H15BrN4O
  8. The crystal structure of imidazolium nitrate, C3H5O3N3
  9. Crystal structure of diiodido-bis(6,6′-dimethoxy-2,2′-(ethane-1,2-diylbis(nitrilomethanylylidene)) diphenolato)tricadmium(II), C36H36Cd3I2N4O8
  10. Crystal structure of [diaqua-bis(2-((1H-tetrazol-1-yl)methyl)-5-carboxy-1H-imidazole-4-carboxylato-κ2 N,O) manganese(II)] dihydrate, C14H18MnN12O12
  11. Crystal structure of Diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-k4 O,O′,N,N′)]iron(II), C13H14FeN4O10
  12. Crystal structure of poly[dimethanol-κ1O-(µ2-(E)-2-((2-oxidobenzylidene)amino)acetato)-(µ3-(E)-2-((2-oxidobenzylidene)amino)acetato)dicadmium(II)], C20H22Cd2N2O8
  13. Crystal structure of N 2,N 6-bis(2-(((E)-quinolin-8-ylmethylene)amino)phenyl)pyridine-2,6-dicarboxamide, C39H27N7O2
  14. An I 6 2 − anion in the crystal structure of theophyllinium triiodide monohydrate, C7H11I3N4O3
  15. The crystal structure of poly[6,6′-oxybis(4-(pyridin-1-ium-1-yl)-1,3,5,2,4,6-trioxatriborinan-2-olate)], [B6O9](C5H5N)2
  16. The crystal structure of (carbonato κ2 O,O′)(2-oxopyridin-1(2H)-olato-κN)tris(trimethylphosphine)rhodium(III) water solvate, C15H33NO5P3Rh
  17. The crystal structure of dibromido-bis((RS)-2-(4-chlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)hexanenitrile-κ1 N)zinc(II), C30H34Br2Cl2N8Zn
  18. Synthesis and crystal structure of 3-(((7-hydroxy-3-(4-hydroxy-3,5-dinitrophenyl)-4-oxo-4H-chromen-8-yl)methyl)(nitroso)amino)propanoic acid, C19H14N4O11
  19. The crystal structure of 3-((4-chloro-N-(2-methoxyethyl)benzamido)methyl)phenyl methanesulfonate, C18H20ClNO5S
  20. Crystal structure of di([1,1′:3′,1″-terphenyl]-2′-yl)tellane, C36H26Te
  21. The crystal structure of diaqua-bis(pyrazolo[1,5-a]-pyrimidine-3-carboxylato-κ2 N,O)zinc(II), C14H12N6O6Zn
  22. Crystal structure of N′,N‴-((1E,2E)-1,2-diphenylethane-1,2-diylidene)bis(4-methylbenzohydrazide) – water – methanol (1/1/1), C31H32N4O4
  23. Crystal structure of 3-((2,4-dichlorobenzyl)thio)-5-methyl-7-(trifluoromethyl)-[1,2,4]triazolo [4,3-c]pyrimidine, C14H9Cl2F3N4S
  24. Crystal structure of 3,5,6,7-tetramethoxy-3′,4′-methylenedioxy-flavone, C20H18O8
  25. Crystal structure of catena-poly[(5,5′-dimethyl-2,2′-bipyridine-κ 2 N,N′)-(μ 3-hydrogen-1,1′,1″-(1,3,5-triazine-2,4,6-triyl)tris(piperidine-4-carboxylato)- κ 5 O:O,O′:O″,O‴)-cadmium(II)], C33H40CdN8O6
  26. The crystal structure of 3,5-bis(propan-2-yl)-1H-pyrazol-4-amine, C9H17N3
  27. Crystal structure of [(1,4,7,10-tetraoxacyclododecane-κ 4 O,O′,O″, O‴)-tris(nitrato-κ 2 O,O′)gadolinium(III)], C8H16N3O13Gd
  28. The crystal structure of 2,2′-((pyridine-2,6-diylbis(methylene))bis(sulfanediyl))-bis(4,5-dihydro-1H-imidazol-3-ium) bromide, C13H19Br2N5S2
  29. Crystal structure of E-2-chloro-N′-(1-(5-chloro-2-hydroxyphenyl)propylidene)benzohydrazide, C16H14Cl2N2O2
  30. Crystal structure of 3-(adamantan-1-yl)-4-methyl-5-{[(4-nitrophenyl)methyl]sulfanyl}-4H-1,2,4-triazole, C20H24N4O2S
  31. The crystal structure of dimethanol-κ1O-(5,10,15,20-tetrakis(4-nitrophenyl)porphyrin-21,23-diido-κ4 O,O′,O″,O′″)manganese(III) trans-dicyanido-κ1C-bis(acetylacetonato-κ2 O,O′)ruthenium(III), C58H46N10O14RuMn
  32. The crystal structure of nitroxyl-κ N-{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl-κN 3)borato}nickel(II), C15H13BF9N7NiO
  33. The crystal structure of [(2,2′-bipyridine-κ2 N,N)-bis(6-phenylpyridine-2-carboxylato- κ2 N,O)nickel(II)] monohydrate, C34H26N4O5Ni
  34. The crystal structure of 5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione, C20H15F5N2O3
  35. The crystal structure of ethyl 2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2H)-yl)benzoate, C14H12F3NO3
  36. [2,2′-{Ethane-1,2-diylbis[(azanylylidene)methanylylidene]}bis(3-bromo-2-hydroxyphenyl)]iron(III) nitrate, C20H12Br2CuN2O2
  37. The crystal structure of 1-(2-iodophenyl)-4-phenyl-1H-1,2,3-triazole, C14H10IN3
  38. Synthesis and crystal structure of 2-(2-oxo-2-(thiophen-2-yl)ethyl)-4H-chromen-4-one, C15H10O3S
  39. {6,6′-((1E,1′E)-((2,2-dimethylpropane-1,3-diyl)bis(azaneylylidene))bis(methaneylylidene))bis(2-bromo-4-chlorophenolate)-κ4N,N′,O,O′}copper(II), C19H16Br2Cl2CuN2O2
  40. The crystal structure of N′-[bis(2-hydroxyphenyl)methylidene]pyridine-4-carbohydrazide, C19H15N3O3
  41. Crystal structure of 2-chloro-6-formylphenolato-κ2O,O′-(6,6′-(((2,2-dimethylpropane-1,3-diyl)bis(azaneylylidene))bis(methaneylylidene))bis(2-chlorophenolato)κ4 N,N,O,O′)cobalt(III), C26H22Cl3CoN2O4
  42. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylate-κ 2 N,O)-bis(μ2-6-phenylpyridine-2-carboxylate-κ 2 O:O′)-bis(μ2-6-phenylpyridine-2-carboxylate-κ 3N,O:O)tetralead(II) C48H32N4O8Pb2
  43. The crystal structure of 3,7-dihydroxy-9-methoxy-4a-methyl-4aH-benzo[c] chromene-2,6-dione —dichloromethane (1/1), C16H14Cl2O6
  44. The crystal structure of (Z)-6-(((5-chloro-2-hydroxyphenyl)amino)methylene)- 4-nitrocyclohexa, C13H9ClN2O4
  45. Crystal structure of dichlorido-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ1 N)zinc(II), C60H68O4N12Cl10Zn
  46. The crystal structure of 4-(2-bromoethoxy)-2-hydroxybenzaldehyde, C9H9BrO3
  47. The crystal structure of 5-azido-1-methyl-4-nitroimidazole, C4H4O2N6
  48. Crystal structure of dibromido-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ 1 N)zinc(II), C60H68O4N12Br2Cl8Zn
  49. Crystal structure of tetrasodium-bis(μ 2-oxido)-hexafluoro-didioxo-molybdenum(V), Na2(Mo2O4F6)
  50. Crystal structure of (E)-N′-(2-chloro-6-hydroxybenzylidene)-4- hydroxybenzohydrazide-water (1/1), C14H13Cl1N2O4
  51. Crystal structure of (E)-N-(4-morpholinophenyl)-1-(quinolin-2-yl)methanimine, C20H19N3O
  52. The crystal structure of catena-poly[(1,10-phenanthroline-κ2 N,N′)-(μ3-2-hydroxybenzene-1,3-dicarboxylato-κ5 O,O′:O″,O‴:O‴)cadmium(II)], C20H12CdN2O5
  53. The crystal structure of 2,6-di-tert-butyl-4-(4-(methylthio)benzylidene)cyclohexa-2,5-dien-1-one, C22H28OS
  54. La3.65Mg30Sb1.07 as a disordered derivative of Th2Ni17-type structure
  55. Crystal structure of (E)-N-(4-morpholinophenyl)-1-(quinoxalin-2-yl)methanimine, C19H18N4O
  56. The crystal structure of 2,2′-(1,2-phenylenebis(methylene))bis(1,3-dimethylisothiouronium) bromide, C14H24Br2N4S2
  57. Crystal structure of tetraaqua-bis[4-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N]zinc(II), C18H20ZnN6O8
  58. Crystal structure of bis(tricarbonyl)-{(S)-(tert-butoxycarbonyl)(1-methoxy-1-oxo-3-sulfido-k2 S:S′-propan-2-yl)amido-k2N:N′}diiron(I) (Fe—Fe), C15H15Fe2NO10S
  59. Crystal structure of (E)-3-((4-chlorophenyl)thio)-4-hydroxypent-3-en-2-one, C11H11ClO2S
  60. The crystal structure of (E)-3′,6′-bis(diethylamino)-2-((5-(diethylamino)-2-hydroxybenzylidene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C39H45N5O3
  61. The crystal structure of 2-(4-methoxynaphthalen-1-yl)-4H-chromen-4-one, C20H14O3
  62. The crystal structure of trans-dichlorido-(ethylenediamine-κ 2 N,N′)-bis(triphenylphosphine-κ 1 P)ruthenium(II), C38H38Cl2N2P2Ru
  63. The double polymeric chain of catena-poly[(μ2-6-bromopyridine-3-carboxylato-κ2 O,O′) (6-bromopyridine-3-carboxylato-κ2 O,O′) (μ2-1,2-bis(4-pyridyl)ethylene-κ2 N:N′)cobalt(II)], C24H16CoBr2N4O4
  64. The crystal structure of tert-butyl 2-(4-(12-bromo [2.2]paracyclophanyl)carbamoyl)pyrrolidine-1-carboxylate, C26H31BrN2O3
  65. The crystal structure of (Z)-2-(2,3-dimethoxybenzylidene)naphtho[1,2-b]furan-3(2H)-one, C21H16O4
  66. Crystal structure of 2-hydroxy-1-tosylindolin-3-yl- 2-naphthoate, C26H21N1S1O5
  67. The crystal structure of 1-methyl-N-(1-methyl-1H-imidazole-2-carbonyl)-1H-imidazole-2-carboxamide, C10H11N5O2
  68. The crystal structure of (E)-2-((5-bromo-2-hydroxybenzylidene)amino)-3′,6′-bis(ethylamino)-2′, 7′-dimethylspiro[isoindoline-1,9′-xanthen]-3-one, C33H31BrN4O3
  69. The crystal structure of dimethanol-5,15-diphenylporphyrin-21,23-diido-κ4 N,Nʹ,Nʺ,Nʹʺ-manganese(III) trans-dicyanido-bis(acetylacetonato-κ2O,Oʹ)ruthenium(III), C46H42N6O6RuMn
  70. Crystal structure of 1,4,8,11-tetraazacyclotetradecane-1,8-diium bis(3,5-dicarboxybenzoate), C28H36N4O12
  71. Bifurcated halogen bonds in the crystal structure of 2,2′-bi(1,8-naphthyridine)—1,4-diiodotetrafluorobenzene (1/1), C22H10F4I2N4
https://doi.org/10.1515/ncrs-2022-0376
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of 1,5-bis(4-chlorophenyl)-3-(3-methylphenyl)pentane- 1,5-dione, C48H40Cl4O4
  4. Crystal structure of (bis(1,10-phenanthroline-κ 2 N,N′))-(3,5-dinitrosalicylato-κ 2 O,O′)nickel(II), C31H18N6NiO7
  5. Crystal structure of {N,N′-bis(4-fluoro-salicylaldehyde)-3,6-dioxa-1,8-diaminooctane-κ4 O,N,N′,O′}zinc(II), C20H20F2N2O4Zn
  6. [5-Bromo-2-(2-(dimethylamino)ethyliminomethyl)phenolato-κ3 N,N′,O]-isothiocyanato-nickel(II), C12H14BrN3NiOS
  7. Crystal structure of 9-bromo-4-(6-methoxypyridin-2-yl)-5,6-dihydrobenzo[h]quinazolin- 2-amine, C18H15BrN4O
  8. The crystal structure of imidazolium nitrate, C3H5O3N3
  9. Crystal structure of diiodido-bis(6,6′-dimethoxy-2,2′-(ethane-1,2-diylbis(nitrilomethanylylidene)) diphenolato)tricadmium(II), C36H36Cd3I2N4O8
  10. Crystal structure of [diaqua-bis(2-((1H-tetrazol-1-yl)methyl)-5-carboxy-1H-imidazole-4-carboxylato-κ2 N,O) manganese(II)] dihydrate, C14H18MnN12O12
  11. Crystal structure of Diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-k4 O,O′,N,N′)]iron(II), C13H14FeN4O10
  12. Crystal structure of poly[dimethanol-κ1O-(µ2-(E)-2-((2-oxidobenzylidene)amino)acetato)-(µ3-(E)-2-((2-oxidobenzylidene)amino)acetato)dicadmium(II)], C20H22Cd2N2O8
  13. Crystal structure of N 2,N 6-bis(2-(((E)-quinolin-8-ylmethylene)amino)phenyl)pyridine-2,6-dicarboxamide, C39H27N7O2
  14. An I 6 2 − anion in the crystal structure of theophyllinium triiodide monohydrate, C7H11I3N4O3
  15. The crystal structure of poly[6,6′-oxybis(4-(pyridin-1-ium-1-yl)-1,3,5,2,4,6-trioxatriborinan-2-olate)], [B6O9](C5H5N)2
  16. The crystal structure of (carbonato κ2 O,O′)(2-oxopyridin-1(2H)-olato-κN)tris(trimethylphosphine)rhodium(III) water solvate, C15H33NO5P3Rh
  17. The crystal structure of dibromido-bis((RS)-2-(4-chlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)hexanenitrile-κ1 N)zinc(II), C30H34Br2Cl2N8Zn
  18. Synthesis and crystal structure of 3-(((7-hydroxy-3-(4-hydroxy-3,5-dinitrophenyl)-4-oxo-4H-chromen-8-yl)methyl)(nitroso)amino)propanoic acid, C19H14N4O11
  19. The crystal structure of 3-((4-chloro-N-(2-methoxyethyl)benzamido)methyl)phenyl methanesulfonate, C18H20ClNO5S
  20. Crystal structure of di([1,1′:3′,1″-terphenyl]-2′-yl)tellane, C36H26Te
  21. The crystal structure of diaqua-bis(pyrazolo[1,5-a]-pyrimidine-3-carboxylato-κ2 N,O)zinc(II), C14H12N6O6Zn
  22. Crystal structure of N′,N‴-((1E,2E)-1,2-diphenylethane-1,2-diylidene)bis(4-methylbenzohydrazide) – water – methanol (1/1/1), C31H32N4O4
  23. Crystal structure of 3-((2,4-dichlorobenzyl)thio)-5-methyl-7-(trifluoromethyl)-[1,2,4]triazolo [4,3-c]pyrimidine, C14H9Cl2F3N4S
  24. Crystal structure of 3,5,6,7-tetramethoxy-3′,4′-methylenedioxy-flavone, C20H18O8
  25. Crystal structure of catena-poly[(5,5′-dimethyl-2,2′-bipyridine-κ 2 N,N′)-(μ 3-hydrogen-1,1′,1″-(1,3,5-triazine-2,4,6-triyl)tris(piperidine-4-carboxylato)- κ 5 O:O,O′:O″,O‴)-cadmium(II)], C33H40CdN8O6
  26. The crystal structure of 3,5-bis(propan-2-yl)-1H-pyrazol-4-amine, C9H17N3
  27. Crystal structure of [(1,4,7,10-tetraoxacyclododecane-κ 4 O,O′,O″, O‴)-tris(nitrato-κ 2 O,O′)gadolinium(III)], C8H16N3O13Gd
  28. The crystal structure of 2,2′-((pyridine-2,6-diylbis(methylene))bis(sulfanediyl))-bis(4,5-dihydro-1H-imidazol-3-ium) bromide, C13H19Br2N5S2
  29. Crystal structure of E-2-chloro-N′-(1-(5-chloro-2-hydroxyphenyl)propylidene)benzohydrazide, C16H14Cl2N2O2
  30. Crystal structure of 3-(adamantan-1-yl)-4-methyl-5-{[(4-nitrophenyl)methyl]sulfanyl}-4H-1,2,4-triazole, C20H24N4O2S
  31. The crystal structure of dimethanol-κ1O-(5,10,15,20-tetrakis(4-nitrophenyl)porphyrin-21,23-diido-κ4 O,O′,O″,O′″)manganese(III) trans-dicyanido-κ1C-bis(acetylacetonato-κ2 O,O′)ruthenium(III), C58H46N10O14RuMn
  32. The crystal structure of nitroxyl-κ N-{hydridotris(3-trifluoromethyl-5-methylpyrazolyl-1-yl-κN 3)borato}nickel(II), C15H13BF9N7NiO
  33. The crystal structure of [(2,2′-bipyridine-κ2 N,N)-bis(6-phenylpyridine-2-carboxylato- κ2 N,O)nickel(II)] monohydrate, C34H26N4O5Ni
  34. The crystal structure of 5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione, C20H15F5N2O3
  35. The crystal structure of ethyl 2,3,5-trifluoro-4-(4-oxo-3,4-dihydropyridin-1(2H)-yl)benzoate, C14H12F3NO3
  36. [2,2′-{Ethane-1,2-diylbis[(azanylylidene)methanylylidene]}bis(3-bromo-2-hydroxyphenyl)]iron(III) nitrate, C20H12Br2CuN2O2
  37. The crystal structure of 1-(2-iodophenyl)-4-phenyl-1H-1,2,3-triazole, C14H10IN3
  38. Synthesis and crystal structure of 2-(2-oxo-2-(thiophen-2-yl)ethyl)-4H-chromen-4-one, C15H10O3S
  39. {6,6′-((1E,1′E)-((2,2-dimethylpropane-1,3-diyl)bis(azaneylylidene))bis(methaneylylidene))bis(2-bromo-4-chlorophenolate)-κ4N,N′,O,O′}copper(II), C19H16Br2Cl2CuN2O2
  40. The crystal structure of N′-[bis(2-hydroxyphenyl)methylidene]pyridine-4-carbohydrazide, C19H15N3O3
  41. Crystal structure of 2-chloro-6-formylphenolato-κ2O,O′-(6,6′-(((2,2-dimethylpropane-1,3-diyl)bis(azaneylylidene))bis(methaneylylidene))bis(2-chlorophenolato)κ4 N,N,O,O′)cobalt(III), C26H22Cl3CoN2O4
  42. The crystal structure of tetrakis(6-phenylpyridine-2-carboxylate-κ 2 N,O)-bis(μ2-6-phenylpyridine-2-carboxylate-κ 2 O:O′)-bis(μ2-6-phenylpyridine-2-carboxylate-κ 3N,O:O)tetralead(II) C48H32N4O8Pb2
  43. The crystal structure of 3,7-dihydroxy-9-methoxy-4a-methyl-4aH-benzo[c] chromene-2,6-dione —dichloromethane (1/1), C16H14Cl2O6
  44. The crystal structure of (Z)-6-(((5-chloro-2-hydroxyphenyl)amino)methylene)- 4-nitrocyclohexa, C13H9ClN2O4
  45. Crystal structure of dichlorido-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ1 N)zinc(II), C60H68O4N12Cl10Zn
  46. The crystal structure of 4-(2-bromoethoxy)-2-hydroxybenzaldehyde, C9H9BrO3
  47. The crystal structure of 5-azido-1-methyl-4-nitroimidazole, C4H4O2N6
  48. Crystal structure of dibromido-tetra((E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol-κ 1 N)zinc(II), C60H68O4N12Br2Cl8Zn
  49. Crystal structure of tetrasodium-bis(μ 2-oxido)-hexafluoro-didioxo-molybdenum(V), Na2(Mo2O4F6)
  50. Crystal structure of (E)-N′-(2-chloro-6-hydroxybenzylidene)-4- hydroxybenzohydrazide-water (1/1), C14H13Cl1N2O4
  51. Crystal structure of (E)-N-(4-morpholinophenyl)-1-(quinolin-2-yl)methanimine, C20H19N3O
  52. The crystal structure of catena-poly[(1,10-phenanthroline-κ2 N,N′)-(μ3-2-hydroxybenzene-1,3-dicarboxylato-κ5 O,O′:O″,O‴:O‴)cadmium(II)], C20H12CdN2O5
  53. The crystal structure of 2,6-di-tert-butyl-4-(4-(methylthio)benzylidene)cyclohexa-2,5-dien-1-one, C22H28OS
  54. La3.65Mg30Sb1.07 as a disordered derivative of Th2Ni17-type structure
  55. Crystal structure of (E)-N-(4-morpholinophenyl)-1-(quinoxalin-2-yl)methanimine, C19H18N4O
  56. The crystal structure of 2,2′-(1,2-phenylenebis(methylene))bis(1,3-dimethylisothiouronium) bromide, C14H24Br2N4S2
  57. Crystal structure of tetraaqua-bis[4-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N]zinc(II), C18H20ZnN6O8
  58. Crystal structure of bis(tricarbonyl)-{(S)-(tert-butoxycarbonyl)(1-methoxy-1-oxo-3-sulfido-k2 S:S′-propan-2-yl)amido-k2N:N′}diiron(I) (Fe—Fe), C15H15Fe2NO10S
  59. Crystal structure of (E)-3-((4-chlorophenyl)thio)-4-hydroxypent-3-en-2-one, C11H11ClO2S
  60. The crystal structure of (E)-3′,6′-bis(diethylamino)-2-((5-(diethylamino)-2-hydroxybenzylidene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C39H45N5O3
  61. The crystal structure of 2-(4-methoxynaphthalen-1-yl)-4H-chromen-4-one, C20H14O3
  62. The crystal structure of trans-dichlorido-(ethylenediamine-κ 2 N,N′)-bis(triphenylphosphine-κ 1 P)ruthenium(II), C38H38Cl2N2P2Ru
  63. The double polymeric chain of catena-poly[(μ2-6-bromopyridine-3-carboxylato-κ2 O,O′) (6-bromopyridine-3-carboxylato-κ2 O,O′) (μ2-1,2-bis(4-pyridyl)ethylene-κ2 N:N′)cobalt(II)], C24H16CoBr2N4O4
  64. The crystal structure of tert-butyl 2-(4-(12-bromo [2.2]paracyclophanyl)carbamoyl)pyrrolidine-1-carboxylate, C26H31BrN2O3
  65. The crystal structure of (Z)-2-(2,3-dimethoxybenzylidene)naphtho[1,2-b]furan-3(2H)-one, C21H16O4
  66. Crystal structure of 2-hydroxy-1-tosylindolin-3-yl- 2-naphthoate, C26H21N1S1O5
  67. The crystal structure of 1-methyl-N-(1-methyl-1H-imidazole-2-carbonyl)-1H-imidazole-2-carboxamide, C10H11N5O2
  68. The crystal structure of (E)-2-((5-bromo-2-hydroxybenzylidene)amino)-3′,6′-bis(ethylamino)-2′, 7′-dimethylspiro[isoindoline-1,9′-xanthen]-3-one, C33H31BrN4O3
  69. The crystal structure of dimethanol-5,15-diphenylporphyrin-21,23-diido-κ4 N,Nʹ,Nʺ,Nʹʺ-manganese(III) trans-dicyanido-bis(acetylacetonato-κ2O,Oʹ)ruthenium(III), C46H42N6O6RuMn
  70. Crystal structure of 1,4,8,11-tetraazacyclotetradecane-1,8-diium bis(3,5-dicarboxybenzoate), C28H36N4O12
  71. Bifurcated halogen bonds in the crystal structure of 2,2′-bi(1,8-naphthyridine)—1,4-diiodotetrafluorobenzene (1/1), C22H10F4I2N4
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 15.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0376/html
Button zum nach oben scrollen